LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 140 filers reported holding LEGEND BIOTECH CORP in Q1 2022. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,542,346 | -3.6% | 276,051 | -0.9% | 0.01% | 0.0% |
| Q2 2023 | $19,226,511 | +47.0% | 278,524 | +2.7% | 0.01% | +20.0% |
| Q1 2023 | $13,083,628 | +16.8% | 271,332 | +21.0% | 0.01% | +25.0% |
| Q4 2022 | $11,197,604 | +27.6% | 224,311 | +4.3% | 0.00% | +33.3% |
| Q3 2022 | $8,774,000 | -23.3% | 215,059 | +3.4% | 0.00% | -25.0% |
| Q2 2022 | $11,435,000 | +74.3% | 207,895 | +15.1% | 0.00% | +100.0% |
| Q1 2022 | $6,562,000 | -5.1% | 180,583 | +21.7% | 0.00% | 0.0% |
| Q4 2021 | $6,915,000 | +5432.0% | 148,370 | +5885.1% | 0.00% | – |
| Q3 2021 | $125,000 | +22.5% | 2,479 | 0.0% | 0.00% | – |
| Q2 2021 | $102,000 | +6.2% | 2,479 | -24.7% | 0.00% | – |
| Q1 2021 | $96,000 | +3.2% | 3,294 | 0.0% | 0.00% | – |
| Q4 2020 | $93,000 | – | 3,294 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $54,715,742 | 20.16% |
| HHLR ADVISORS, LTD. | 6,436,533 | $432,341,922 | 9.65% |
| Paradigm Biocapital Advisors LP | 2,025,480 | $136,051,492 | 9.23% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,828 | $75,487,527 | 9.13% |
| RA Capital Management | 6,264,707 | $420,800,369 | 8.28% |
| Iron Triangle Partners LP | 452,629 | $30,403,090 | 4.44% |
| Nicholas Investment Partners, LP | 593,010 | $39,832,482 | 2.98% |
| Old Well Partners, LLC | 45,200 | $3,036,084 | 2.63% |
| Avidity Partners Management LP | 967,000 | $64,953,390 | 2.62% |
| E Fund Management (Hong Kong) Co., Ltd. | 52,759 | $3,544 | 2.23% |